Literature DB >> 15380143

Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome.

L Moran1, R J Norman.   

Abstract

Polycystic ovary syndrome (PCOS) is a common clinical and metabolic condition in women of reproductive age. It is associated with short-term reproductive and long-term metabolic dysfunction. Treatment has traditionally focused on fertility and hormonal therapy. However, general obesity, central obesity and insulin resistance are strongly implicated in its aetiology and improving these factors has proved highly successful in some clinical situations, reducing the need for costly assisted reproduction. A low-fat, high-carbohydrate diet is thought to improve insulin sensitivity, aid in weight loss and reduction of metabolic and reproductive symptoms and improve the long-term maintenance of a reduced weight. However, there has been recent community interest in adopting a protocol advocating a moderate increase in dietary protein for improving weight loss and PCOS symptoms. Altering the glycaemic index of the diet has also received considerable attention as a regime for promoting satiety and reducing metabolic risk factors for type 2 diabetes mellitus and cardiovascular disease. Exercise and other lifestyle changes are essential for altering the short- and long-term effects of PCOS. It is vital that the efficacy of these strategies is assessed so that accurate medical and dietetic advice can be given both to patients and to the health-care community.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15380143     DOI: 10.1016/j.bpobgyn.2004.05.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  7 in total

Review 1.  Gender differences in the metabolic syndrome and their role for cardiovascular disease.

Authors:  V Regitz-Zagrosek; E Lehmkuhl; M O Weickert
Journal:  Clin Res Cardiol       Date:  2006-01-30       Impact factor: 5.460

2.  Lack of an association between CYP1A1 gene Ile462Val polymorphism and polycystic ovary syndrome in Chinese.

Authors:  Binbin Wang; Jing Wang; Jingjing Liu; Feng Ni; Jinting Yan; Sirui Zhou; Yuan Mu; Yunxia Cao; Xu Ma
Journal:  Endocrine       Date:  2009-06-09       Impact factor: 3.633

Review 3.  Insulin and hyperandrogenism in women with polycystic ovary syndrome.

Authors:  Catherine G Baptiste; Marie-Claude Battista; Andréanne Trottier; Jean-Patrice Baillargeon
Journal:  J Steroid Biochem Mol Biol       Date:  2009-12-28       Impact factor: 4.292

Review 4.  Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome.

Authors:  Haigang Ding; Juan Zhang; Feng Zhang; Songou Zhang; Xiaozhen Chen; Wenqing Liang; Qiong Xie
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-20       Impact factor: 5.555

5.  Development of Chinese Version of Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (Chi-PCOSQ).

Authors:  Huang-tz Ou; Meng-Hsing Wu; Chung-Ying Lin; Pei-Chi Chen
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

6.  Weight loss for women with and without polycystic ovary syndrome following a very low-calorie diet in a community-based setting with trained facilitators for 12 weeks.

Authors:  Efsevia A Nikokavoura; Kelly L Johnston; John Broom; Wendy L Wrieden; Catherine Rolland
Journal:  Diabetes Metab Syndr Obes       Date:  2015-10-14       Impact factor: 3.168

7.  The role of a pulse-based diet on infertility measures and metabolic syndrome risk: protocol of a randomized clinical trial in women with polycystic ovary syndrome.

Authors:  Laura E McBreairty; Philip D Chilibeck; Donna R Chizen; Roger A Pierson; Lindsay Tumback; Lauren B Sherar; Gordon A Zello
Journal:  BMC Nutr       Date:  2017-03-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.